(Q37221773)

19 August 2017

1 reference

title

GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival (English)

1 reference

19 August 2017

J Buteau

1

1 reference

19 August 2017

publication date

1 February 2008

1 reference

19 August 2017

published in

Diabetes and Metabolism

1 reference

19 August 2017

volume

34 Suppl 2

1 reference

19 August 2017

page(s)

S73-7

1 reference

Introduction: Globalization and the non-communicable disease epidemic

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Five stages of evolving beta-cell dysfunction during progression to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

beta-Cell death during progression to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

New drug targets for type 2 diabetes and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

The biology of incretin hormones

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Structure-Function of the Glucagon Receptor Family of G Protein-Coupled Receptors: The Glucagon, GIP, GLP-1, and GLP-2 Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Integrative mitogenic role of protein kinase B/Akt in beta-cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973398-6

7 January 2021

10.1016/S1262-3636(08)73398-6

Identifiers

DOI

1 reference

19 August 2017

1 reference